2014 has proven to be yet another successful year! As it comes to a close, SWHR would be remiss not to reflect on what has been an incredible year.
Nanette K. Wenger, MD, MACC, MACP, FAHA, Professor of Medicine (Cardiology) Emeritus Emory University School of Medicine, Consultant to the Emory Heart and Vascular Center, and former SWHR Board Member and Chair of the Award has received the 2015 Bernadine Healy Leadership in Women’s CV Disease Award from the Awards Committee and Board of Trustees of the American College of Cardiology.
Washington, D.C.—The U.S. Food and Drug Administration (FDA) released data today on a dedicated website from six studies reflecting a two-month period in response to a requirement under the “FDA Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data” to make transparent the percentage of female and minority participation in clinical trials for medications intended for all populations. “I am pleased by this action step by FDA,” said Phyllis Greenberger, President and CEO of the Society for Women’s Health Research (SWHR®), “but the news is discouraging. The data validates the concern we have expressed to the FDA for 25 years.”